How do patients with heart failure with preserved ejection fraction die?, Eur J Heart Fail, vol.15, pp.604-613, 2013. ,
,
,
Developing Therapies for Heart Failure With Preserved Ejection Fraction: Current State and Future Directions, JACC Heart Fail, vol.2, pp.97-112, 2014. ,
,
,
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur J Heart Fail, vol.18, pp.891-975, 2016. ,
,
Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction, Eur J Heart Fail, vol.16, pp.992-1001, 2014. ,
Microvascular endothelial dysfunction in heart failure with preserved ejection fraction, Heart, vol.102, pp.257-259, 2016. ,
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation, J Am Coll Cardiol, vol.62, pp.263-271, 2013. ,
Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach, Circ Cardiovasc Genet, vol.10, issue.1, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01446558
,
Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study, Arch Cardiovasc Dis, vol.107, pp.112-121, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01147020
Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and-II, J Biol Chem, vol.271, pp.30322-30325, 1996. ,
IGFBP7 binds to the IGF1 receptor and blocks its activation by insulin-like growth factors, Sci Signal, vol.5, p.92, 2012. ,
,
, Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria, Mol Cell Biochem, vol.386, pp.233-249, 2014.
,
, Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial, JACC Heart Fail, vol.4, pp.860-869, 2016.
Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?, Am J Cardiol, vol.114, pp.1543-1549, 2014. ,
Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure, Proteomics, vol.13, pp.2324-2334, 2013. ,
Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction, J Card Fail, vol.23, pp.20-28, 2017. ,
Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling, J Cardiovasc Transl Res, vol.7, pp.250-261, 2014. ,
,
Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction, Eur J Heart Fail, vol.11, pp.198-204, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00911681
,
Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1, J Card Fail, vol.23, pp.293-303, 1017. ,
HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin, Int J Cardiol, vol.228, pp.709-716, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01446565
Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction, BMC Cardiovasc Disord, vol.16, p.199, 2016. ,
TIMP-2] x [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure, Clin Cardiol, vol.40, pp.485-491, 2017. ,
Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population, Sci Rep, vol.5, p.10227, 2015. ,
Role of ,
URL : https://hal.archives-ouvertes.fr/hal-00356231
, Serum Biomarkers in Early Detection of Diabetic Cardiomyopathy in the West Virginian Population, Int J Med Sci, vol.13, pp.161-168, 2016.
Leptin and vascular smooth muscle, Curr Vasc Pharmacol, vol.4, pp.383-393, 2006. ,
,
, Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells, Int Immunol, vol.14, pp.1273-1282, 2002.
Elevated expression of angiomodulin (AGM/IGFBP-rP1) in tumor stroma and its roles in fibroblast activation, Cancer Sci, vol.103, pp.691-699, 2012. ,
,
IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival, Cell Death Dis, vol.5, p.1300, 2014. ,
,
,
Spironolactone for heart failure with preserved ejection fraction, N Engl J Med, vol.370, pp.1383-1392, 2014. ,
,
Irbesartan in patients with heart failure and preserved ejection fraction, N Engl J Med, vol.359, pp.2456-2467, 2008. ,
, , vol.14, p.28
, Suppression of Tumorigenicity 2 (ng/mL) 23 (16;30) 35 (23;51)
, Galectin-3 (ng/mL) 17 (13, vol.21, p.17
Baseline characteristics in the 22 LVAD and 34 HTx patients. Continuous variables are presented as median and interquartile range (lower and upper quartiles; Q1;Q3) and categorical variables as numbers (n) and % when not otherwise stated ,